The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity.

MLA

Minari, Tatiana Palotta, et al. “The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity.” Obesities, vol. 4, no. 4, Dec. 2024, pp. 412–26. EBSCOhost, https://doi.org/10.3390/obesities4040033.

APA

Minari, T. P., Manzano, C. F., Tácito Yugar, L. B., Sedenho-Prado, L. G., Rubio, T. de A., Tácito, L. H. B., Pires, A. C., Vilela-Martin, J. F., Cosenso-Martin, L. N., Ludovico, N. D., Fattori, A., Yugar-Toledo, J. C., Moreno, H., & Pisani, L. P. (2024). The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity. Obesities, 4(4), 412–426. https://doi.org/10.3390/obesities4040033

Chicago

Minari, Tatiana Palotta, Carolina Freitas Manzano, Louise Buonalumi Tácito Yugar, Luis Gustavo Sedenho-Prado, Tatiane de Azevedo Rubio, Lúcia Helena Bonalumi Tácito, Antônio Carlos Pires, et al. 2024. “The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity.” Obesities 4 (4): 412–26. doi:10.3390/obesities4040033.